Tag: Mantle cell lymphoma

Home / Mantle cell lymphoma

Categories

Accelerated approval is granted by FDA to pirtobrutinib for relapsed or refractory mantle cell lymphoma

Feb 2023: Accelerated approval is granted by FDA to pirtobrutinib (Jaypirca, Eli Lilly and Company) for relapsed or refractory mantle cell lymphoma. In BRUIN (NCT03740529), an open-label, multicente...
mantle-cell-lymphoma

Scan the code